A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Corona Virus Disease 2019 (COVID-19)
Detection Principle
ImmunoAssay-Antibody
Target
IgM/IgG on S-protein
Testing Method Category
Testing Method
ELISA in-house-method
Testing Method - Additional Info
Peptide-based luminescent immunoassay
Reported Performance
Sensitivity: 71.4% (IgG), 57.2% (IgM), 81, 5% (IgG+IgM)
Sample Size
276 patient
Peer-reviewed
no
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements